Cabaletta Bio (CABA) Cash from Investing Activities (2019 - 2025)

Cabaletta Bio's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at $49.8 million for Q4 2025.

• On a quarterly basis, Cash from Investing Activities rose 310.71% year-over-year to $49.8 million in Q4 2025; TTM through Dec 2025 was -$50.3 million, a 206.3% decrease from a year earlier, with the FY2025 full-year figure at -$50.3 million, down 206.3% from the prior year.
• Cash from Investing Activities improved to $49.8 million in Q4 2025 per CABA's latest filing, from -$50.1 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $49.8 million in Q4 2025 and bottomed at -$50.1 million in Q3 2025.
• The 5-year median for Cash from Investing Activities is $938000.0 (2021), against an average of -$2.3 million.
• Across the five-year window, Cash from Investing Activities sank 5261.02% in 2023 and soared 18941.54% in 2024, its largest moves.
• Year by year, Cash from Investing Activities stood at $849000.0 in 2021, then slumped by 137.22% to -$316000.0 in 2022, then surged by 459.49% to $1.1 million in 2023, then surged by 967.25% to $12.1 million in 2024, then jumped by 310.71% to $49.8 million in 2025.
• Per Business Quant, the three latest CABA Cash from Investing Activities figures stand at $49.8 million (Q4 2025), -$50.1 million (Q3 2025), and -$49.2 million (Q2 2025).